Check out $NCNA !

Check out $NuCana (NCNA.US)$ ! Under $1.50 a share right now!

Some things to consider:

- NuCana’s market cap is not reflecting the potential of two other drug candidates NUC-3373 and NUC-7738, currently in Phase 2 trials.

- The UK and EU proceedings against Gilead for alleged years-long infringement of an EU patent have important hearing dates lined up in January and March 2023. Total overdue license fees / damages could be about $920 million, and infringement is ongoing at $450 million in EU sales per year.

- A reasonable 6% royalty could lead to a total of $920 million in overdue license fees / damages, and infringement by Gilead still ongoing.

- Cash runway until 2025 and almost 900 patents granted.

https://seekingalpha.com/article/4568532-nucana-pipeline-and-major-gilead-litigation-progressing-nicely